A historical overview of magnetic resonance imaging, focusing on technological innovations

Investigative Radiology

Volumn 47, Issue 12, 2012, Pages 725-741

  Ai, Tao ^a   Morelli, John N ^b   Hu, Xuemei ^a   Hao, Dapeng ^c   Goerner, Frank L ^d   Ager, Bryan ^d   Runge, Val M ^d  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^c QINGDAO UNIVERSITY   (China)

^d University of Texas Medical Branch School of Medicine   (United States)

Author keywords

contrast enhanced MRI; diffusion weighted imaging; functional MRI; history of MRI; magnetic resonance imaging; nuclear magnetic resonance

Indexed keywords

EP 2104R; GADOBENATE DIMEGLUMINE; GADOFOSVESET; GADOLINIUM CHELATE; GADOLINIUM PENTETATE MEGLUMINE; GADOTERATE MEGLUMINE; GADOXETIC ACID; UNCLASSIFIED DRUG;

BLOOD OXYGENATION; BOLD SIGNAL; BRAIN BLOOD VOLUME; BRAIN ISCHEMIA; CARDIAC GATED IMAGING; CARDIAC IMAGING; CELL VIABILITY; CEREBROSPINAL FLUID; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; ECHO PLANAR IMAGING; ELECTROCARDIOGRAM; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GRAY MATTER; HUMAN; IMAGE QUALITY; IMAGING SYSTEM; INFORMATION PROCESSING; MAGNETIC FIELD; MAGNETIC RESONANCE ANGIOGRAPHY; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RADIOFREQUENCY; REVIEW; SIGNAL NOISE RATIO; TRACTOGRAPHY; WHITE MATTER; WHOLE BODY MRI;

EID: 84870064211     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e318272d29f     Document Type: Review

References (415)

1. Bloch F, Hanson W, Packard M. Nuclear infraction. Phys Rev. 1946;69:127.
2. Purcell E, Torrey H, Pound R. Resonance absorption by nuclear magnetic moments in a solid. Phys Rev. 1946;69:37-38.
3. Hahn EL. Spin echoes. Phys Rev. 1950;80:580-594.
4. Ernst RR. Nuclear magnetic double resonance with an incoherent radio-frequency field. J Chem Phys. 1966;45:3845.
5. Damadian R. Tumor detection by nuclear magnetic resonance. Science. 1971;171:1151-1153.
6. Lauterbur PC. Image formation by induced local interactions: examples of employing nuclear magnetic resonance. Nature. 1973;242:190-191.
7. Mansfield P, Grannell PK. NMR ''diffraction'' in solids? J Phys C: Solid State Phys. 1973;6:L422-L426.
8. Mansfield P, Maudsley AA. Medical imaging by NMR. Br J Radiol. 1977; 50:188-194.
9. Damadian R, Goldsmith M, Minkoff L. NMR in cancer, XVI: FONAR image of the live human body. Physiol Chem Phys. 1977;9:97-100, 108.
10. Edelstein WA, Hutchison JM, Johnson G, et al. Spin warp NMR imaging and applications to human whole-body imaging. Phys Med Biol. 1980;25:751-756.
11. Hinshaw WS, Bottomley PA, Holland GN. Radiographic thin-section image of the human wrist by nuclear magnetic resonance. Nature. 1977;270:722-723.
12. Holland GN, Hawkes RC, Moore WS. Nuclear magnetic resonance (NMR) tomography of the brain: coronal and sagittal sections. J Comput Assist Tomogr. 1980;4:429-433.
13. Wesbey GE, Moseley ME, Ehman RL. Translational molecular self-diffusion in magnetic resonance imaging, II: measurement of the self-diffusion coefficient. Invest Radiol. 1984;19:491-498.
14. Wesbey GE, Moseley ME, Ehman RL. Translational molecular self-diffusion in magnetic resonance imaging, I: effects on observed spin-spin relaxation. Invest Radiol. 1984;19:484-490.
15. Le Bihan D, Breton E, Lallemand D, et al. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology. 1986;161:401-407.
16. Moseley ME, Cohen Y, Kucharczyk J, et al. Diffusion-weighted MR imaging of anisotropic water diffusion in cat central nervous system. Radiology. 1990;176:439-445.
17. Ogawa S, Lee TM, Kay AR, et al. Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci U S A. 1990;87:9868-9872.
18. Ai T, Padua A, Goerner F, et al. SEMAC-VAT and MSVAT-SPACE sequence strategies for metal artifact reduction in 1.5T magnetic resonance imaging. Invest Radiol. 2012;47:267-276.
19. Lin C, Itti E, Luciani A, et al. Whole-body diffusion-weighted imaging with apparent diffusion coefficient mapping for treatment response assessment in patients with diffuse large B-cell lymphoma: pilot study. Invest Radiol. 2011;46:341-349.
20. Kraff O, Bitz AK, Breyer T, et al. A transmit/receive radiofrequency array for imaging the carotid arteries at 7 Tesla: coil design and first in vivo results. Invest Radiol. 2011;46:246-254.
21. Posin JP, Arakawa M, Crooks LE, et al. Hydrogen MR imaging of the head at 0.35 T and 0.7 T: effects of magnetic field strength. Radiology. 1985;157:679-683.
22. Keeler EK, Giambalvo A, Smith SD, et al. Initial assessment of the performance of an 0.3 T permanent magnet in whole body NMR imaging. Physiol Chem Phys Med NMR. 1983;15:319-335.
23. Bryan PJ, Butler HE, LiPuma JP, et al. NMR scanning of the pelvis: initial experience with a 0.3 T system. AJR Am J Roentgenol. 1983;141:1111-1118.
24. McFarland EW, Rosen BR. NMR instrumentation and hardware available at present and in the future. Cardiovasc Intervent Radiol. 1986;8:238-250.
25. Oldendorf W. Low field strength magnetic scanners. J Comput Assist Tomogr. 1985;9:1153-1154.
26. Marti-Bonmati L, Kormano M. MR equipment acquisition strategies: low-field or high-field scanners. Eur Radiol. 1997;7(suppl 5):263-268.
27. Blanco RT, Ojala R, Kariniemi J, et al. Interventional and intraoperative MRI at low field scanner-a review. Eur J Radiol. 2005;56:130-142.
28. Bottomley PA, Hart HR Jr, Edelstein WA, et al. Anatomy and metabolism of the normal human brain studied by magnetic resonance at 1.5 Tesla. Radiology. 1984;150:441-446.
29. Soher BJ, Dale BM, Merkle EM. A review of MR physics:3T versus 1.5T. Magn Reson Imaging Clin N Am. 2007;15:277-290, v.
30. Vaughan T, DelaBarre L, Snyder C, et al. 9.4T human MRI: preliminary results. Magn Reson Med. 2006;56:1274-1282.
31. Bartha R, Michaeli S, Merkle H, et al. In vivo 1H2O T2+ measurement in the human occipital lobe at 4T and 7T by Carr-Purcell MRI: detection of microscopic susceptibility contrast. Magn Reson Med. 2002;47:742-750.
32. Akella SV, Regatte RR, Gougoutas AJ, et al. Proteoglycan-induced changes in T1rho-relaxation of articular cartilage at 4T. Magn Reson Med. 2001;46:419-423.
33. Tallantyre EC, Morgan PS, Dixon JE, et al. A comparison of 3Tand 7T in the detection of small parenchymal veins within MS lesions. Invest Radiol. 2009;44:491-494.
34. Vaughan JT, Garwood M, Collins CM, et al. 7T vs. 4T: RF power, homogeneity, and signal-to-noise comparison in head images. Magn Reson Med. 2001;46:24-30.
35. Maubon AJ, Ferru JM, Berger V, et al. Effect of field strength on MR images: comparison of the same subject at 0.5, 1.0, and 1.5 T. Radiographics. 1999; 19:1057-1067.
36. Edelstein WA, Glover GH, Hardy CJ, et al. The intrinsic signal-to-noise ratio in NMR imaging. Magn Reson Med. 1986;3:604-618.
37. Ladd ME. High-field-strength magnetic resonance: potential and limits. To p Magn Reson Imaging. 2007;18:139-152.
38. Kanal E, Shellock FG, Talagala L. Safety considerations in MR imaging. Radiology. 1990;176:593-606.
39. Yamaguchi-Sekino S, Sekino M, Ueno S. Biological effects of electromagnetic fields and recently updated safety guidelines for strong static magnetic fields. Magn Reson Med Sci. 2011;10:1-10.
40. de Vocht F, Stevens T, Glover P, et al. Cognitive effects of head-movements in stray fields generated by a 7 Tesla whole-body MRI magnet. Bioelec-tromagnetics. 2007;28:247-255.
41. de Vocht F, van Drooge H, Engels H, et al. Exposure, health complaints and cognitive performance among employees of an MRI scanners manufacturing department. J Magn Reson Imaging. 2006;23:197-204.
42. de Vocht F, van-Wendel-de-Joode B, Engels H, et al. Neurobehavioral effects among subjects exposed to high static and gradient magnetic fields from a 1.5 Tesla magnetic resonance imaging systemVa case-crossover pilot study. Magn Reson Med. 2003;50:670-674.
43. International Electrotechnical Commission. Medical electrical equipmentV Part 2-33: Particular requirements for the basic safety and essential performance of magnetic resonance equipment for medical diagnosis. 2010; http://webstore.iec.ch/webstore/webstore.nsf/artnum/043851. Accessed August 27, 2012.
44. Umutlu L, Kraff O, Orzada S, et al. Dynamic contrast-enhanced renal MRI at 7 Tesla: preliminary results. Invest Radiol. 2011;46:425-433.
45. Korteweg MA, Veldhuis WB, Visser F, et al. Feasibility of 7 Tesla breast magnetic resonance imaging determination of intrinsic sensitivity and highresolution magnetic resonance imaging, diffusion-weighted imaging, and (1)H-magnetic resonance spectroscopy of breast cancer patients receiving neoadjuvant therapy. Invest Radiol. 2011;46:370-376.
46. Rothschild PA, Domesek JM, Eastham ME, et al. MR imaging of excessively obese patients: the use of an open permanent magnet. Magn Reson Imaging. 1991;9:151-154.
47. Lu DS, Sinha S, Lucas J, et al. MR-guided percutaneous ethanol ablation of liver tissue in a.2-T open MR system: preliminary study in porcine model. J Magn Reson Imaging. 1997;7:303-308.
48. Michel SC, Rake A, Gotzmann L, et al. Pelvimetry and patient acceptability compared between open 0.5-T and closed 1.5-T MR systems. Eur Radiol. 2002;12:2898-2905.
49. Bangard C, Paszek J, Berg F, et al. MR imaging of claustrophobic patients in an open 1.0T scanner: motion artifacts and patient acceptability compared with closed bore magnets. Eur J Radiol. 2007;64:152-157.
50. Notohamiprodjo M, Dietrich O, Horger W, et al. Diffusion tensor imaging (DTI) of the kidney at 3 tesla-feasibility, protocol evaluation and comparison to 1.5 Tesla. Invest Radiol. 2010;45:245-254.
51. Ingrisch M, Sourbron S, Morhard D, et al. Quantification of perfusion and permeability in multiple sclerosis: dynamic contrast-enhanced MRI in 3D at 3T. Invest Radiol. 2012;47:252-258.
52. Dewey M, Schink T, Dewey CF. Claustrophobia during magnetic resonance imaging: cohort study in over 55, 000 patients. J Magn Reson Imaging. 2007; 26:1322-1327.
53. Hoult DI, Richards RE. The signal-to-noise ratio of the nuclear magnetic resonance experiment. 1976. J Magn Reson. 2011;213:329-343.
54. Ackerman JJ, Grove TH, Wong GG, et al. Mapping of metabolites in whole animals by 31P NMR using surface coils. Nature. 1980;283:167-170.
55. Axel L. Surface coil magnetic resonance imaging. J Comput Assist Tomogr. 1984;8:381-384.
56. Edelstein WA, Schenck JF, Hart HR, et al. Surface coil magnetic resonance imaging. JAMA. 1985;253:828.
57. Hoult DI, Chen CN, Sank VJ. Quadrature detection in the laboratory frame. Magn Reson Med. 1984;1:339-353.
58. Yamada Y, Jinzaki M, Tanami Y, et al. Model-based iterative reconstruction technique for ultralow-dose computed tomography of the lung: a pilot study. Invest Radiol. 2012;47:482-489.
59. Sigovan M, Kaye E, Lancelot E, et al. Anti-inflammatory drug evaluation in ApoE-/-mice by ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging. Invest Radiol. 2012;47:546-552.
60. Jeon KN, Goo JM, Lee CH, et al. Computer-aided nodule detection and volumetry to reduce variability between radiologists in the interpretation of lung nodules at low-dose screening computed tomography. Invest Radiol. 2012;47:457-461.
61. Perisinakis K, Seimenis I, Tzedakis A, et al. Screening computed tomography colonography with 256-slice scanning: should patient radiation burden and associated cancer risk constitute a major concern? Invest Radiol. 2012;47:451-456.
62. Roemer PB, Edelstein WA, Hayes CE, et al. The NMR phased array. Magn Reson Med. 1990;16:192-225.
63. Carlson JW, Minemura T. Imaging time reduction through multiple receiver coil data acquisition and image reconstruction. Magn Reson Med. 1993;29:681-687.
64. Ra JB, Rim CY. Fast imaging using subencoding data sets from multiple detectors. Magn Reson Med. 1993;30:142-145.
65. Prechtel HW, Verburg FA, Palmowski M, et al. Different intravenous contrast media concentrations do not affect clinical assessment of 18F-fluorodeox-yglucose positron emission tomography/computed tomography scans in an intraindividual comparison. Invest Radiol. 2012;47:497-502.
66. Bauner KU, Biffar A, Theisen D, et al. Extracellular volume fractions in chronic myocardial infarction. Invest Radiol. 2012;47:538-545.
67. Bettinger T, Bussat P, Tardy I, et al. Ultrasound molecular imaging contrast agent binding to both e-and p-selectin in different species. Invest Radiol. 2012;47:516-523.
68. Fink C, Brix G, Halliburton SS, et al. Functional computed tomography imaging. Invest Radiol. 2012;47:1.
69. Ren Y, Fleischmann D, Foygel K, et al. Antiangiogenic and radiation therapy: early effects on in vivo computed tomography perfusion parameters in human colon cancer xenografts in mice. Invest Radiol. 2012;47:25-32.
70. Apfaltrer P, Meyer M, Meier C, et al. Contrast-enhanced dual-energy CT of gastrointestinal stromal tumors: is iodine-related attenuation a potential indicator of tumor response? Invest Radiol. 2012;47:65-70.
71. Felmlee JP, Ehman RL, Riederer SJ, et al. Adaptive motion compensation in MRI: accuracy of motion measurement. Magn Reson Med. 1991;18:207-213.
72. Korin HW, Felmlee JP, Ehman RL, et al. Adaptive technique for three-dimensional MR imaging of moving structures. Radiology. 1990;177:217-221.
73. Ehman RL, Felmlee JP. Adaptive technique for high-definition MR imaging of moving structures. Radiology. 1989;173:255-263.
74. Taylor AM, Jhooti P, Wiesmann F, et al. MR navigator-echo monitoring of temporal changes in diaphragm position: implications for MR coronary an-giography. J Magn Reson Imaging. 1997;7:629-636.
75. McConnell MV, Khasgiwala VC, Savord BJ, et al. Comparison of respiratory suppression methods and navigator locations for MR coronary angiography. AJR Am J Roentgenol. 1997;168:1369-1375.
76. Oshinski JN, Hofland L, Mukundan S Jr, et al. Two-dimensional coronary MR angiography without breath holding. Radiology. 1996;201:737-743.
77. Taylor AM, Jhooti P, Keegan J, et al. Magnetic resonance navigator echo diaphragm monitoring in patients with suspected diaphragm paralysis. J Magn Reson Imaging. 1999;9:69-74.
78. Moghari MH, Chan RH, Hong SN, et al. Free-breathing cardiac MR with a fixed navigator efficiency using adaptive gating window size. Magn Reson Med. 2012. [Epub ahead of print].
79. Liu J, Drangova M. Rapid six-degree-of-freedom motion detection using prerotated baseline spherical navigator echoes. Magn Reson Med. 2011;65:506-514.
80. Kohler MO, Denis de Senneville B, Quesson B, et al. Spectrally selective pencil-beam navigator for motion compensation of MR-guided high-intensity focused ultrasound therapy of abdominal organs. Magn Reson Med. 2011;66:102-111.
81. Hackenbroch M, Nehrke K, Gieseke J, et al. 3D motion adapted gating (3D MAG): a new navigator technique for accelerated acquisition of free breathing navigator gated 3D coronary MR-angiography. Eur Radiol. 2005;15:1598-1606.
82. Lanzer P, Botvinick EH, Schiller NB, et al. Cardiac imaging using gated magnetic resonance. Radiology. 1984;150:121-127.
83. Fletcher BD, Jacobstein MD, Nelson AD, et al. Gated magnetic resonance imaging of congenital cardiac malformations. Radiology. 1984;150:137-140.
84. Runge VM, Clanton JA, Partain CL, et al. Respiratory gating in magnetic resonance imaging at 0.5 Tesla. Radiology. 1984;151:521-523.
85. Ehman RL, McNamara MT, Pallack M, et al. Magnetic resonance imaging with respiratory gating: techniques and advantages. AJR Am J Roentgenol. 1984;143:1175-1182.
86. Rubin JB, Enzmann DR, Wright A. CSF-gated MR imaging of the spine: theory and clinical implementation. Radiology. 1987;163:784-792.
87. Wittsack HJ, Lanzman RS, Quentin M, et al. Temporally resolved electrocardiogram-triggered diffusion-weighted imaging of the human kidney: correlation between intravoxel incoherent motion parameters and renal blood flow at different time points of the cardiac cycle. Invest Radiol. 2012;47:226-230.
88. Carr HY, Purcell EM. Effects of diffusion on free precession in nuclear magnetic resonance experiments. Phys Rev. 1954;94:630-638.
89. Meiboom S, Gill D. Modified spin-echo method for measuring nuclear relaxation times. Rev Sci Instrum. 1958;29:688-691.
90. Young IR, Burl M, Clarke GJ, et al. Magnetic resonance properties of hydrogen: imaging the posterior fossa. AJR Am J Roentgenol. 1981;137:895-901.
91. Bailes DR, Young IR, Thomas DJ, et al. NMR imaging of the brain using spinecho sequences. Clin Radiol. 1982;33:395-414.
92. Hendrick RE, Nelson TR, Hendee WR. Optimizing tissue contrast in magnetic resonance imaging. Magn Reson Imaging. 1984;2:193-204.
93. Perman WH, Hilal SK, Simon HE, et al. Contrast manipulation in NMR imaging. Magn Reson Imaging. 1984;2:23-32.
94. Hennig J, Nauerth A, Friedburg H. RARE imaging: a fast imaging method for clinical MR. Magn Reson Med. 1986;3:823-833.
95. Mulkern RV, Wong ST, Winalski C, et al. Contrast manipulation and artifact assessment of 2D and 3D RARE sequences. Magn Reson Imaging. 1990;8:557-566.
96. Listerud J, Einstein S, Outwater E, Kressel HY. First principles of fast spin echo. Magn Reson Q. 1992;8:199-244.
97. Jones KM, Mulkern RV, Schwartz RB, et al. Fast spin-echo MR imaging of the brain and spine: current concepts. AJR Am J Roentgenol. 1992;158:1313-1320.
98. Jones KM, Mulkern RV, Mantello MT, et al. Brain hemorrhage: evaluation with fast spin-echo and conventional dual spin-echo images. Radiology. 1992; 182:53-58.
99. Partovi S, Fram EK, Karis JP. Fast spin echo MR imaging. Neuroimaging Clin N Am. 1999;9:553-576.
100. Semelka RC, Kelekis NL, Thomasson D, et al. HASTE MR imaging: description of technique and preliminary results in the abdomen. J Magn Reson Imaging. 1996;6:698-699.
101. Stevens KJ, Wallace CG, Chen W, et al. Imaging of the wrist at 1.5 Tesla using isotropic three-dimensional fast spin echo cube. J Magn Reson Imaging. 2011;33:908-915.
102. Notohamiprodjo M, Horng A, Pietschmann MF, et al. MRI of the knee at 3T: first clinical results with an isotropic PDfs-weighted 3D-TSE-sequence. Invest Radiol. 2009;44:585-597.
103. Notohamiprodjo M, Kuschel B, Horng A, et al. 3D-MRI of the ankle with optimized 3D-SPACE. Invest Radiol. 2012;47:231-239.
104. Frahm J, Haase A, Matthaei D. Rapid NMR imaging of dynamic processes using the FLASH technique. Magn Reson Med. 1986;3:321-327.
105. Haase A, Frahm J, Matthaei D, et al. FLASH imaging: rapid NMR imaging using low flip-angle pulses. J Magn Reson. 1986;67:258-266.
106. Evans AJ, Hedlund LW, Herfkens RJ, et al. Evaluation of steady and pulsatile flow with dynamic MRI using limited flip angles and gradient refocused echoes. Magn Reson Imaging. 1987;5:475-482.
107. Nayler GL, Firmin DN, Longmore DB. Blood flow imaging by cine magnetic resonance. J Comput Assist Tomogr. 1986;10:715-722.
108. Atlas SW, Mark AS, Grossman RI, et al. Intracranial hemorrhage: gradientecho MR imaging at 1.5 T: comparison with spin-echo imaging and clinical applications. Radiology. 1988;168:803-807.
109. Chandarana H, Block TK, Rosenkrantz AB, et al. Free-breathing radial 3D fat-suppressed T1-weighted gradient echo sequence: a viable alternative for contrast-enhanced liver imaging in patients unable to suspend respiration. Invest Radiol. 2011;46:648-653.
110. Crooks L, Arakawa M, Hoenninger J, et al. Nuclear magnetic resonance whole-body imager operating at 3.5 KGauss. Radiology. 1982;143:169-174.
111. Hyman RA, Edwards JH, Vacirca SJ, et al. 0.6 T MR imaging of the cervical spine: multislice and multiecho techniques. AJNR Am J Neuroradiol. 1985;6:229-236.
112. Kulkarni MV, Narayana PA, McArdle CB, et al. Cervical spine MR imaging using multislice gradient echo imaging: comparison with cardiac gated spin echo. Magn Reson Imaging. 1988;6:517-525.
113. Kucharczyk W, Crawley AP, Kelly WM, et al. Effect of multislice interference on image contrast in T2-and T1-weighted MR images. AJNR Am J Neuror-adiol. 1988;9:443-451.
114. Weaver JB. Simultaneous multislice acquisition of MR images. Magn Reson Med. 1988;8:275-284.
115. Slavin GS, Rettmann DW. Addressing efficiency and residual magnetization cross talk in multi-slice 2D steady-state free precession imaging of the heart. Magn Reson Med. 2005;53:965-969.
116. Oh CH, Hilal SK, Mun IK, et al. An optimized multislice acquisition sequence for the inversion-recovery MR imaging. Magn Reson Imaging. 1991; 9:903-908.
117. Johnson G, Wadghiri YZ, Turnbull DH. 2D multislice and 3D MRI sequences are often equally sensitive. Magn Reson Med. 1999;41:824-828.
118. Sievers B, Schrader S, Hunold P, et al. Free breathing 2D multi-slice real-time gradient-echo cardiovascular magnetic resonance imaging: impact on left ventricular function measurements compared with standard multi-breath hold 2D steady-state free precession imaging. Acta Cardiol. 2011;66:489-497.
119. Kramer DM, Schneider JS, Rudin AM, et al. True 3-dimensional nuclear magnetic resonance zeugmatographic images of a human brain. Neuroradi-ology. 1981;21:239-244.
120. Frahm J, Haase A, Matthaei D. Rapid three-dimensional MR imaging using the FLASH technique. J Comput Assist Tomogr. 1986;10:363-368.
121. Harms SE, Muschler G. Three-dimensional MR imaging of the knee using surface coils. J Comput Assist Tomogr. 1986;10:773-777.
122. Runge VM, Wood ML, Kaufman DM, et al. FLASH: clinical three-dimensional magnetic resonance imaging. Radiographics. 1988;8:947-965.
123. Deshpande VS, Shea SM, Laub G, et al. 3D magnetization-prepared true-FISP: a new technique for imaging coronary arteries. Magn Reson Med. 2001;46:494-502.
124. Fan Z, Hodnett PA, Davarpanah AH, et al. Noncontrast magnetic resonance angiography of the hand: improved arterial conspicuity by multidirectional flow-sensitive dephasing magnetization preparation in 3D balanced steady-state free precession imaging. Invest Radiol. 2011;46:515-523.
125. Neira C, Anzidei M, Napoli A, et al. Investigation of the longitudinal relaxation rate of blood after gadobenate dimeglumine administration: sequence optimization, dynamic acquisition, and clinical impact for contrast-enhanced MR angiography of the carotid arteries. Invest Radiol. 2011;46:774-782.
126. Jung JY, Jee WH, Park MY, et al. Meniscal tear configurations: categorization with 3D isotropic turbo spin-echo MRI compared with conventional MRI at 3 T. AJR Am J Roentgenol. 2012;198:W173-W180.
127. Lee H, Kim EY, Yang KS, et al. Susceptibility-resistant variable-flip-angle turbo spin echo imaging for reliable estimation of cortical thickness: a feasibility study. Neuroimage. 2012;59:377-388.
128. Chen CA, Kijowski R, Shapiro LM, et al. Cartilage morphology at 3.0T: assessment of three-dimensional magnetic resonance imaging techniques. J Magn Reson Imaging. 2010;32:173-183.
129. Feinberg DA, Hale JD, Watts JC, et al. Halving MR imaging time by conjugation: demonstration at 3.5 kG. Radiology. 1986;161:527-531.
130. MacFall JR, Pelc NJ, Vavrek RM. Correction of spatially dependent phase shifts for partial Fourier imaging. Magn Reson Imaging. 1988;6:143-155.
131. Runge VM, Wood ML. Half-Fourier MR imaging of CNS disease. AJNR Am J Neuroradiol. 1990;11:77-82.
132. Babourina-Brooks B, Cowin GJ, Wang D. Diffusion-weighted imaging in the prostate: an apparent diffusion coefficient comparison of half-Fourier acquisition single-shot turbo spin-echo and echo planar imaging. Magn Reson Imaging. 2012;30:189-194.
133. Doyle FH, Gore JC, Pennock JM, et al. Imaging of the brain by nuclear magnetic resonance. Lancet. 1981;2:53-57.
134. Young IR, Hall AS, Pallis CA, et al. Nuclear magnetic resonance imaging of the brain in multiple sclerosis. Lancet. 1981;2:1063-1066.
135. Ehman RL, Gray JE, Bryant RG, et al. Spin-spin relaxation time (T2) dependence in MR saturation-and inversion-recovery images. AJR Am J Roentgenol. 1984;143:903-906.
136. Panush D, Fulbright R, Sze G, et al. Inversion-recovery fast spin-echo MR imaging: efficacy in the evaluation of head and neck lesions. Radiology. 1993;187:421-426.
137. Elster AD. Gradient-echo MR imaging: techniques and acronyms. Radiology. 1993;186:1-8.
138. Stehling MK, Ordidge RJ, Coxon R, et al. Inversion-recovery echo-planar imaging (IR-EPI) at 0.5 T. Magn Reson Med. 1990;13:514-517.
139. Bydder GM, Young IR. MR imaging: clinical use of the inversion recovery sequence. J Comput Assist Tomogr. 1985;9:659-675.
140. Bydder GM, Hajnal JV, Young IR. MRI: use of the inversion recovery pulse sequence. Clin Radiol. 1998;53:159-176.
141. Bydder GM, Steiner RE, Young IR, et al. Clinical NMR imaging of the brain:140 cases. AJR Am J Roentgenol. 1982;139:215-236.
142. White SJ, Hajnal JV, Young IR, et al. Use of fluid-attenuated inversion-recovery pulse sequences for imaging the spinal cord. Magn Reson Med. 1992;28:153-162.
143. Hajnal JV, Bryant DJ, Kasuboski L, et al. Use of fluid attenuated inversion recovery (FLAIR) pulse sequences in MRI of the brain. J Comput Assist Tomogr. 1992;16:841-844.
144. Rydberg JN, Hammond CA, Huston J 3rd, et al. T1-weighted MR imaging of the brain using a fast inversion recovery pulse sequence. J Magn Reson Imaging. 1996;6:356-362.
145. Listerud J, Mitchell J, Bagley L, et al. OIL FLAIR: optimized interleaved fluid-attenuated inversion recovery in 2D fast spin echo. Magn Reson Med. 1996;36:320-325.
146. Rydberg JN, Hammond CA, Grimm RC, et al. Initial clinical experience in MR imaging of the brain with a fast fluid-attenuated inversion-recovery pulse sequence. Radiology. 1994;193:173-180.
147. Bink A, Schmitt M, Gaa J, et al. Detection of lesions in multiple sclerosis by 2D FLAIR and single-slab 3D FLAIR sequences at 3.0 T: initial results. Eur Radiol. 2006;16:1104-1110.
148. Chagla GH, Busse RF, Sydnor R, et al. Three-dimensional fluid attenuated inversion recovery imaging with isotropic resolution and nonselective adia-batic inversion provides improved three-dimensional visualization and cere-brospinal fluid suppression compared to two-dimensional flair at 3 tesla. Invest Radiol. 2008;43:547-551.
149. Polak P, Magnano C, Zivadinov R, et al. 3D FLAIRED:3D fluid attenuated inversion recovery for enhanced detection of lesions in multiple sclerosis. Magn Reson Med. 2012;68:874-881.
150. Mathews VP, Caldemeyer KS, Lowe MJ, et al. Brain: gadolinium-enhanced fast fluid-attenuated inversion-recovery MR imaging. Radiology. 1999;211:257-263.
151. Pipe JG. Motion correction with PROPELLER MRI: application to head motion and free-breathing cardiac imaging. Magn Reson Med. 1999;42:963-969.
152. Wintersperger BJ, Runge VM, Biswas J, et al. Brain magnetic resonance imaging at 3 tesla using BLADE compared with standard rectilinear data sampling. Invest Radiol. 2006;41:586-592.
153. Naganawa S, Satake H, Iwano S, et al. Contrast-enhanced MR imaging of the brain using T1-weighted FLAIR with BLADE compared with a conventional spin-echo sequence. Eur Radiol. 2008;18:337-342.
154. Dietrich TJ, Ulbrich EJ, Zanetti M, et al. PROPELLER technique to improve image quality of MRI of the shoulder. AJR Am J Roentgenol. 2011;197: W1093-W1100.
155. Forbes KP, Pipe JG, Karis JP, et al. Improved image quality and detection of acute cerebral infarction with PROPELLER diffusion-weighted MR imaging. Radiology. 2002;225:551-555.
156. Hirokawa Y, Isoda H, Okada T, et al. Improved detection of hepatic metastases from pancreatic cancer using periodically rotated overlapping parallel lines with enhanced reconstruction (PROPELLER) technique after SPIO administration. Invest Radiol. 2010;45:158-164.
157. Forbes KP, Pipe JG, Bird CR, et al. PROPELLER MRI: clinical testing of a novel technique for quantification and compensation of head motion. J Magn Reson Imaging. 2001;14:215-222.
158. Mugler JP, 3rd, Brookeman Jr. Three-dimensional magnetization-prepared rapid gradient-echo imaging (3D MP RAGE). Magn Reson Med. 1990;15:152-157.
159. Mugler JP 3rd, Spraggins TA, Brookeman Jr. T2-weighted three-dimensional MP-RAGE MR imaging. J Magn Reson Imaging. 1991;1:731-737.
160. Mugler JP 3rd, Brookeman Jr. Rapid three-dimensional T1-weighted MR imaging with the MP-RAGE sequence. J Magn Reson Imaging. 1991;1:561-567.
161. de Lange EE, Mugler JP 3rd, Bertolina JA, et al. Magnetization prepared rapid gradient-echo (MP-RAGE) MR imaging of the liver: comparison with spinecho imaging. Magn Reson Imaging. 1991;9:469-476.
162. Runge VM, Kirsch JE, Thomas GS, et al. Clinical comparison of three-dimensional MP-RAGE and FLASH techniques for MR imaging of the head. J Magn Reson Imaging. 1991;1:493-500.
163. Altun E, Semelka RC, Dale BM, et al. Water excitation MPRAGE: an alternative sequence for postcontrast imaging of the abdomen in noncooperative patients at 1.5 Tesla and 3.0 Tesla MRI. J Magn Reson Imaging. 2008;27:1146-1154.
164. Stocker T, Shah NJ. MP-SAGE: A new MP-RAGE sequence with enhanced SNR and CNR for brain imaging utilizing square-spiral phase encoding and variable flip angles. Magn Reson Med. 2006;56:824-834.
165. Kober T, Granziera C, Ribes D, et al. MP2RAGE multiple sclerosis magnetic resonance imaging at 3 T. Invest Radiol. 2012;47:346-352.
166. Mugler JP 3rd, Bao S, Mulkern RV, et al. Optimized single-slab three-dimensional spin-echo MR imaging of the brain. Radiology. 2000;216:891-899.
167. Lichy MP, Wietek BM, Mugler JP 3rd, et al. Magnetic resonance imaging of the body trunk using a single-slab, 3-dimensional, T2-weighted turbo-spinecho sequence with high sampling efficiency (SPACE) for high spatial resolution imaging: initial clinical experiences. Invest Radiol. 2005;40:754-760.
168. Arizono S, Isoda H, Maetani YS, et al. High-spatial-resolution three-dimensional MR cholangiography using a high-sampling-efficiency technique (SPACE) at 3T: comparison with the conventional constant flip angle sequence in healthy volunteers. J Magn Reson Imaging. 2008;28:685-690.
169. Viallon M, Vargas MI, Jlassi H, et al. High-resolution and functional magnetic resonance imaging of the brachial plexus using an isotropic 3D T2 STIR (short term inversion recovery) SPACE sequence and diffusion tensor imaging. Eur Radiol. 2008;18:1018-1023.
170. Mihai G, Chung YC, Merchant A, et al. T1-weighted-SPACE dark blood whole body magnetic resonance angiography (DB-WBMRA): initial experience. J Magn Reson Imaging. 2010;31:502-509.
171. Stevens KJ, Busse RF, Han E, et al. Ankle: isotropic MR imaging with 3D-FSE-cubeVinitial experience in healthy volunteers. Radiology. 2008;249:1026-1033.
172. Syha R, Wurslin C, Ketelsen D, et al. Automated volumetric assessment of the Achilles tendon (AVAT) using a 3D T2 weighted SPACE sequence at 3T in healthy and pathologic cases. Eur J Radiol. 2012;81:1612-1617.
173. Kato Y, Higano S, Tamura H, et al. Usefulness of contrast-enhanced T1-weighted sampling perfection with application-optimized contrasts by using different flip angle evolutions in detection of small brain metastasis at 3T MR imaging: comparison with magnetization-prepared rapid acquisition of gradient echo imaging. AJNR Am J Neuroradiol. 2009;30:923-929.
174. Rossi M, Ruottinen H, Elovaara I, et al. Brain iron deposition and sequence characteristics in Parkinsonism: comparison of SWI, T(2)*maps, T(2)-weighted-, and FLAIR-SPACE. Invest Radiol. 2010;45:795-802.
175. Haystead CM, Dale BM, Merkle EM. N/2 ghosting artifacts: elimination at 3.0-T MR cholangiography with SPACE pulse sequence. Radiology. 2008; 246:589-595.
176. Baumert B, Wortler K, Steffinger D, et al. Assessment of the internal cra-niocervical ligaments with a new magnetic resonance imaging sequence: three-dimensional turbo spin echo with variable flip-angle distribution (SPACE). Magn Reson Imaging. 2009;27:954-960.
177. Shahid KR, Spinner RJ, Skinner JA, et al. Evaluation of intraneural ganglion cysts using three-dimensional fast spin echo-cube. J Magn Reson Imaging. 2010;32:714-718.
178. Ordidge RJ, Mansfield P, Doyle M, et al. Real time movie images by NMR. Br J Radiol. 1982;55:729-733.
179. Ordidge RJ, Mansfield P, Coupland RE. Rapid biomedical imaging by NMR. Br J Radiol. 1981;54:850-855.
180. Kwong KK. Functional magnetic resonance imaging with echo planar imaging. Magn Reson Q. 1995;11:1-20.
181. Turner R, Le Bihan D, Chesnick AS. Echo-planar imaging of diffusion and perfusion. Magn Reson Med. 1991;19:247-253.
182. Butts K, Riederer SJ, Ehman RL, et al. Interleaved echo planar imaging on a standard MRI system. Magn Reson Med. 1994;31:67-72.
183. Laub GA, Kaiser WA. MR angiography with gradient motion refocusing. J Comput Assist Tomogr. 1988;12:377-382.
184. Marchal G, Bosmans H, Van Fraeyenhoven L, et al. Intracranial vascular lesions: optimization and clinical evaluation of three-dimensional time-offlight MR angiography. Radiology. 1990;175:443-448.
185. Masaryk TJ, Laub GA, Modic MT, et al. Carotid-CNS MR flow imaging. Magn Reson Med. 1990;14:308-314.
186. Mattle HP, Wentz KU, Edelman RR, et al. Cerebral venography with MR. Radiology. 1991;178:453-458.
187. Parker DL, Yuan C, Blatter DD. MR angiography by multiple thin slab 3D acquisition. Magn Reson Med. 1991;17:434-451.
188. Revel D, Loubeyre P, Delignette A, et al. Contrast-enhanced magnetic resonance tomoangiography: a new imaging technique for studying thoracic great vessels. Magn Reson Imaging. 1993;11:1101-1105.
189. Loubeyre P, Revel D, Douek P, et al. Dynamic contrast-enhanced MR angi-ography of pulmonary embolism: comparison with pulmonary angiography. AJR Am J Roentgenol. 1994;162:1035-1039.
190. Prince MR. Gadolinium-enhanced MR aortography. Radiology. 1994;191:155-164.
191. Wilson GJ, Hoogeveen RM, Willinek WA, et al. Parallel imaging in MR an-giography. Top Magn Reson Imaging. 2004;15:169-185.
192. Fenchel M, Doering J, Seeger A, et al. Ultrafast whole-body MR angiography with two-dimensional parallel imaging at 3.0 T: feasibility study. Radiology. 2009;250:254-263.
193. Lum DP, Busse RF, Francois CJ, et al. Increased volume of coverage for abdominal contrast-enhanced MR angiography with two-dimensional auto-calibrating
194. Anzidei M, Napoli A, Zaccagna F, et al. First-pass and high-resolution steady-state magnetic resonance angiography of the peripheral arteries with gado-benate dimeglumine: an assessment of feasibility and diagnostic performance. Invest Radiol. 2011;46:307-316.
195. Jeffery D, Emery DJ, Wilman AH. Effects of cardiac motion on 3D contrast-enhanced MR angiography of the carotid arteries. J Magn Reson Imaging. 2011;34:532-538.
196. Mostardi PM, Glockner JF, Young PM, et al. Contrast-enhanced MR angi-ography of the abdomen with highly accelerated acquisition techniques. Radiology. 2011;261:587-597.
197. Wagner M, Rosler R, Lembcke A, et al. Whole-heart coronary magnetic resonance angiography at 1.5 Tesla: does a blood-pool contrast agent improve diagnostic accuracy? Invest Radiol. 2011;46:152-159.
198. Moran PR. A flow velocity zeugmatographic interlace for NMR imaging in humans. Magn Reson Imaging. 1982;1:197-203.
199. Bryant DJ, Payne JA, Firmin DN, et al. Measurement of flow with NMR imaging using a gradient pulse and phase difference technique. J Comput Assist Tomogr. 1984;8:588-593.
200. Moran PR, Moran RA, Karstaedt N. Verification and evaluation of internal flow and motion: true magnetic resonance imaging by the phase gradient modulation method. Radiology. 1985;154:433-441.
201. Koerte IK, Schankin CJ, Immler S, et al. Altered cerebrovenous drainage in patients with migraine as assessed by phase-contrast magnetic resonance imaging. Invest Radiol. 2011;46:434-440.
202. Dumoulin CL, Souza SP, Walker MF, et al. Three-dimensional phase contrast angiography. Magn Reson Med. 1989;9:139-149.
203. Walker MF, Souza SP, Dumoulin CL. Quantitative flow measurement in phase contrast MR angiography. J Comput Assist Tomogr. 1988;12:304-313.
204. Hausmann R, Lewin JS, Laub G. Phase-contrast MR angiography with reduced acquisition time: new concepts in sequence design. J Magn Reson Imaging. 1991;1:415-422.
205. Huston J 3rd, Ehman RL. Comparison of time-of-flight and phase-contrast MR neuroangiographic techniques. Radiographics. 1993;13:5-19.
206. Markl M, Harloff A, Bley TA, et al. Time-resolved 3D MR velocity mapping at 3T: improved navigator-gated assessment of vascular anatomy and blood flow. J Magn Reson Imaging. 2007;25:824-831.
207. Gu T, Korosec FR, Block WF, et al. PC VIPR: a high-speed 3D phase-contrast method for flow quantification and high-resolution angiography. AJNR Am J Neuroradiol. 2005;26:743-749.
208. Frydrychowicz A, Markl M, Hirtler D, et al. Aortic hemodynamics in patients with and without repair of aortic coarctation: in vivo analysis by 4D flow-sensitive magnetic resonance imaging. Invest Radiol. 2011;46:317-325.
209. Weininger M, Sagmeister F, Herrmann S, et al. Hemodynamic assessment of severe aortic stenosis: MRI evaluation of dynamic changes of vena contracta. Invest Radiol. 2011;46:1-10.
210. Korosec FR, Frayne R, Grist TM, et al. Time-resolved contrast-enhanced 3D MR angiography. Magn Reson Med. 1996;36:345-351.
211. Seng K, Maderwald S, de Greiff A, et al. Dynamic contrast-enhanced magnetic resonance angiography of the thoracic vessels: an intraindividual comparison of different k-space acquisition strategies. Invest Radiol. 2010;45:708-714.
212. Nishimura S, Hirai T, Shigematsu Y, et al. Evaluation of brain and head and neck tumors with 4D contrast-enhanced MR angiography at 3T. AJNR Am J Neuroradiol. 2012;33:445-448.
213. Delfaut EM, Beltran J, Johnson G, et al. Fat suppression in MR imaging: techniques and pitfalls. Radiographics. 1999;19:373-382.
214. Dixon WT. Simple proton spectroscopic imaging. Radiology. 1984;153:189-194.
215. Haase A, Frahm J, Hanicke W, et al. 1H NMR chemical shift selective (CHESS) imaging. Phys Med Biol. 1985;30:341-344.
216. Bydder GM, Pennock JM, Steiner RE, et al. The short TI inversion recovery sequenceVan approach to MR imaging of the abdomen. Magn Reson Imaging. 1985;3:251-254.
217. Meyer CH, Pauly JM, Macovski A, et al. Simultaneous spatial and spectral selective excitation. Magn Reson Med. 1990;15:287-304.
218. Ma J. Dixon techniques for water and fat imaging. J Magn Reson Imaging. 2008;28:543-558.
219. Ryoo I, Lee JM, Chung YE, et al. Gadobutrol-enhanced, three-dimensional, dynamic MR imaging with MR cholangiography for the preoperative evaluation of bile duct cancer. Invest Radiol. 2010;45:217-224.
220. Frahm J, Haase A, Hanicke W, et al. Chemical shift selective MR imaging using a whole-body magnet. Radiology. 1985;156:441-444.
221. Matthaei D, Frahm J, Haase A, et al. Chemical-shift-selective magnetic-resonance imaging of avascular necrosis of the femoral head. Lancet. 1985; 1:370-371.
222. Bley TA, Wieben O, Francois CJ, et al. Fat and water magnetic resonance imaging. J Magn Reson Imaging. 2010;31:4-18.
223. Bydder GM, Steiner RE, Blumgart LH, et al. MR imaging of the liver using short TI inversion recovery sequences. J Comput Assist Tomogr. 1985;9:1084-1089.
224. Hauger O, Dumont E, Chateil JF, et al. Water excitation as an alternative to fat saturation in MR imaging: preliminary results in musculoskeletal imaging. Radiology. 2002;224:657-663.
225. Mori K, Takahashi N, Hiratsuka M, et al. Detection of hepatic metastases using ferucarbotran-enhanced MR imaging: feasibility and diagnostic accuracy of three-dimensional sensitivity-encoding water-excitation multishot echo-planar sequence (3D-SWEEP). J Magn Reson Imaging. 2006;24:1110-1116.
226. Yuan J, Madore B, Panych LP. Fat-water selective excitation in balanced steady-state free precession using short spatial-spectral RF pulses. J Magn Reson. 2011;208:219-224.
227. Belliveau JW, Rosen BR, Kantor HL, et al. Functional cerebral imaging by susceptibility-contrast NMR. Magn Reson Med. 1990;14:538-546.
228. Rosen BR, Belliveau JW, Aronen HJ, et al. Susceptibility contrast imaging of cerebral blood volume: human experience. Magn Reson Med. 1991;22:293-299; discussion 300-303.
229. Runge VM, Kirsch JE, Wells JW, et al. Assessment of cerebral perfusion by first-pass, dynamic, contrast-enhanced, steady-state free-precession MR imaging: an animal study. AJR Am J Roentgenol. 1993;160:593-600.
230. Huisman TA, Sorensen AG. Perfusion-weighted magnetic resonance imaging of the brain: techniques and application in children. Eur Radiol. 2004;14:59-72.
231. Detre JA, Leigh JS, Williams DS, et al. Perfusion imaging. Magn Reson Med. 1992;23:37-45.
232. Detre JA, Rao H, Wang DJ, et al. Applications of arterial spin labeled MRI in the brain. J Magn Reson Imaging. 2012;35:1026-1037.
233. Luciani A, Vignaud A, Cavet M, et al. Liver cirrhosis: intravoxel incoherent motion MR imagingVpilot study. Radiology. 2008;249:891-899.
234. Le Bihan D. Intravoxel incoherent motion perfusion MR imaging: a wake-up call. Radiology. 2008;249:748-752.
235. Stejskal EO, Tanner J. Spin diffusion measurements: spin echoes in the presence of a time-dependent field gradient. J Chem Phys. 1965;42:288.
236. Morelli JN, Runge VM, Feiweier T, et al. Evaluation of a modified Stejskal-Tanner diffusion encoding scheme, permitting a marked reduction in TE, in diffusion-weighted imaging of stroke patients at 3 T. Invest Radiol. 2010;45:29-35.
237. Moseley ME, Cohen Y, Mintorovitch J, et al. Early detection of regional cerebral ischemia in cats: comparison of diffusion-and T2-weighted MRI and spectroscopy. Magn Reson Med. 1990;14:330-346.
238. Chien D, Kwong KK, Gress DR, et al. MR diffusion imaging of cerebral infarction in humans. AJNR Am J Neuroradiol. 1992;13:1097-1102; discussion 1103-1095.
239. Chandarana H, Lee VS, Hecht E, et al. Comparison of biexponential and monoexponential model of diffusion weighted imaging in evaluation of renal lesions: preliminary experience. Invest Radiol. 2011;46:285-291.
240. Curvo-Semedo L, Lambregts DM, Maas M, et al. Diffusion-weighted MRI in rectal cancer: apparent diffusion coefficient as a potential noninvasive marker of tumor aggressiveness. J Magn Reson Imaging. 2012;35:1365-1371.
241. Kim YK, Lee MW, Lee WJ, et al. Diagnostic accuracy and sensitivity of diffusion-weighted and of gadoxetic acid-enhanced 3-T MR imaging alone or in combination in the detection of small liver metastasis (e1.5 cm in diameter). Invest Radiol. 2012;47:159-166.
242. Douek P, Turner R, Pekar J, et al. MR color mapping of myelin fiber orientation. J Comput Assist Tomogr. 1991;15:923-929.
243. Mori S, van Zijl PC. Diffusion weighting by the trace of the diffusion tensor within a single scan. Magn Reson Med. 1995;33:41-52.
244. Tievsky AL, Ptak T, Farkas J. Investigation of apparent diffusion coefficient and diffusion tensor anisotrophy in acute and chronic multiple sclerosis lesions. AJNR Am J Neuroradiol. 1999;20:1491-1499.
245. Manenti G, Carlani M, Mancino S, et al. Diffusion tensor magnetic resonance imaging of prostate cancer. Invest Radiol. 2007;42:412-419.
246. Eyal E, Shapiro-Feinberg M, Furman-Haran E, et al. Parametric diffusion tensor imaging of the breast. Invest Radiol. 2012;47:284-291.
247. Doyle FH, Pennock JM, Banks LM, et al. Nuclear magnetic resonance imaging of the liver: initial experience. AJR Am J Roentgenol. 1982;138:193-200.
248. Buonocore E, Borkowski GP, Pavlicek W, et al. NMR imaging of the abdomen: technical considerations. AJR Am J Roentgenol. 1983;141:1171-1178.
249. Bailes DR, Gilderdale DJ, Bydder GM, et al. Respiratory ordered phase encoding (ROPE): a method for reducing respiratory motion artefacts in MR imaging. J Comput Assist Tomogr. 1985;9:835-838.
250. Lewis CE, Prato FS, Drost DJ, et al. Comparison of respiratory triggering and gating techniques for the removal of respiratory artifacts in MR imaging. Radiology. 1986;160:803-810.
251. Mitchell DG, Vinitski S, Burk DL Jr, et al. Motion artifact reduction in MR imaging of the abdomen: gradient moment nulling versus respiratory-sorted phase encoding. Radiology. 1988;169:155-160.
252. Klessen C, Asbach P, Kroencke TJ, et al. Magnetic resonance imaging of the upper abdomen using a free-breathing T2-weighted turbo spin echo sequence with navigator triggered prospective acquisition correction. J Magn Reson Imaging. 2005;21:576-582.
253. Zech CJ, Herrmann KA, Huber A, et al. High-resolution MR-imaging of the liver with T2-weighted sequences using integrated parallel imaging: comparison of prospective motion correction and respiratory triggering. J Magn Reson Imaging. 2004;20:443-450.
254. Hawkes RC, Holland GN, Moore WS, et al. Nuclear magnetic resonance (NMR) tomography of the normal heart. J Comput Assist Tomogr. 1981;5:605-612.
255. Lanzer P, Barta C, Botvinick EH, et al. ECG-synchronized cardiac MR imaging: method and evaluation. Radiology. 1985;155:681-686.
256. Scott AD, Keegan J, Firmin DN. Motion in cardiovascular MR imaging. Radiology. 2009;250:331-351.
257. Larson AC, White RD, Laub G, et al. Self-gated cardiac cine MRI. Magn Reson Med. 2004;51:93-102.
258. Crowe ME, Larson AC, Zhang Q, et al. Automated rectilinear self-gated cardiac cine imaging. Magn Reson Med. 2004;52:782-788.
259. Kim WS, Mun CW, Kim DJ, et al. Extraction of cardiac and respiratory motion cycles by use of projection data and its applications to NMR imaging. Magn Reson Med. 1990;13:25-37.
260. Wang Y, Winchester PA, Yu L, et al. Breath-hold three-dimensional contrast-enhanced coronary MR angiography: motion-matched k-space sampling for reducing cardiac motion effects. Radiology. 2000;215:600-607.
261. Niendorf T, Sodickson DK. Parallel imaging in cardiovascular MRI: methods and applications. NMR Biomed. 2006;19:325-341.
262. Fries P, Mamann A, Seidel R, et al. Comparison of retrospectively self-gated and prospectively triggered FLASH sequences for cine imaging of the aorta in mice at 9.4 tesla. Invest Radiol. 2012;47:259-266.
263. Ogawa S, Lee TM, Nayak AS, et al. Oxygenation-sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields. Magn Reson Med. 1990;14:68-78.
264. Kwong KK, Belliveau JW, Chesler DA, et al. Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proc Natl Acad Sci U S A. 1992;89:5675-5679.
265. Ogawa S, Tank DW, Menon R, et al. Intrinsic signal changes accompanying sensory stimulation: functional brain mapping with magnetic resonance imaging. Proc Natl Acad Sci U S A. 1992;89:5951-5955.
266. Howard RJ, Bullmore E, Brammer M, et al. Activation of area V5 by visual perception of motion demonstrated with echoplanar MR imaging. Magn Reson Imaging. 1995;13:907-909.
267. Ebrahimi B, Gloviczki M, Woollard JR, et al. Compartmental analysis of renal BOLD MRI data: introduction and validation. Invest Radiol. 2012;47:175-182.
268. Warner L, Glockner JF, Woollard J, et al. Determinations of renal cortical and medullary oxygenation using blood oxygen level-dependent magnetic resonance imaging and selective diuretics. Invest Radiol. 2011;46:41-47.
269. Partovi S, Schulte AC, Jacobi B, et al. Blood oxygenation level-dependent (BOLD) MRI of human skeletal muscle at 1.5 and 3 T. J Magn Reson Imaging. 2012;35:1227-1232.
270. Behar KL, den Hollander JA, Stromski ME, et al. High-resolution 1H nuclear magnetic resonance study of cerebral hypoxia in vivo. Proc Natl Acad Sci U S A. 1983;80:4945-4948.
271. Bottomley PA, Edelstein WA, Foster TH, et al. In vivo solvent-suppressed localized hydrogen nuclear magnetic resonance spectroscopy: a window to metabolism? Proc Natl Acad Sci U S A. 1985;82:2148-2152.
272. Frahm J, Bruhn H, Gyngell ML, et al. Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo. Magn Reson Med. 1989;9:79-93.
273. Frahm J, Bruhn H, Gyngell ML, et al. Localized proton NMR spectroscopy in different regions of the human brain in vivo: relaxation times and concentrations of cerebral metabolites. Magn Reson Med. 1989;11:47-63.
274. Burtscher IM, Holtas S. Proton magnetic resonance spectroscopy in brain tumours: clinical applications. Neuroradiology. 2001;43:345-352.
275. Sibtain NA, Howe FA, Saunders DE. The clinical value of proton magnetic resonance spectroscopy in adult brain tumours. Clin Radiol. 2007;62:109-119.
276. Castillo M, Kwock L, Mukherji SK. Clinical applications of proton MR spectroscopy. AJNR Am J Neuroradiol. 1996;17:1-15.
277. Dorrius MD, Pijnappel RM, Jansen-van der Weide MC, et al. Determination of choline concentration in breast lesions: quantitative multivoxel proton MR spectroscopy as a promising noninvasive assessment tool to exclude benign lesions. Radiology. 2011;259:695-703.
278. Russo F, Mazzetti S, Grignani G, et al. In vivo characterisation of soft tissue tumours by 1.5-T proton MR spectroscopy. Eur Radiol. 2012;22:1131-1139.
279. Bonekamp S, Shen J, Salibi N, et al. Early response of hepatic malignancies to locoregional therapy-value of diffusion-weighted magnetic resonance imaging and proton magnetic resonance spectroscopy. J Comput Assist Tomogr. 2011;35:167-173.
280. Stanwell P, Russell P, Carter J, et al. Evaluation of ovarian tumors by proton magnetic resonance spectroscopy at three tesla. Invest Radiol. 2008;43:745-751.
281. Sodickson DK, Manning WJ. Simultaneous acquisition of spatial harmonics (SMASH): fast imaging with radiofrequency coil arrays. Magn Reson Med. 1997;38:591-603.
282. Sodickson DK, Griswold MA, Jakob PM, et al. Signal-to-noise ratio and signal-to-noise efficiency in SMASH imaging. Magn Reson Med. 1999;41:1009-1022.
283. Griswold MA, Jakob PM, Heidemann RM, et al. Generalized autocalibrating partially parallel acquisitions (GRAPPA). Magn Reson Med. 2002;47:1202-1210.
284. Heidemann RM, Griswold MA, Haase A, et al. VD-AUTO-SMASH imaging. Magn Reson Med. 2001;45:1066-1074.
285. Griswold MA, Jakob PM, Nittka M, et al. Partially parallel imaging with localized sensitivities (PILS). Magn Reson Med. 2000;44:602-609.
286. Pruessmann KP, Weiger M, Scheidegger MB, et al. SENSE: sensitivity encoding for fast MRI. Magn Reson Med. 1999;42:952-962.
287. Goerner FL, Clarke GD. Measuring signal-to-noise ratio in partially parallel imaging MRI. Med Phys. 2011;38:5049-5057.
288. Kellman P, Epstein FH, McVeigh ER. Adaptive sensitivity encoding incorporating temporal filtering (TSENSE). Magn Reson Med. 2001;45:846-852.
289. Breuer FA, Kellman P, Griswold MA, et al. Dynamic autocalibrated parallel imaging using temporal GRAPPA (TGRAPPA). Magn Reson Med. 2005; 53:981-985.
290. Stalder AF, Dong Z, Yang Q, et al. Four-dimensional flow-sensitive MRI of the thoracic aorta:12-versus 32-channel coil arrays. J Magn Reson Imaging. 2012;35:190-195.
291. Wiggins GC, Polimeni JR, Potthast A, et al. 96-Channel receive-only head coil for 3 tesla: design optimization and evaluation. Magn Reson Med. 2009;62:754-762.
292. Schmitt M, Potthast A, Sosnovik DE, et al. A 128-channel receive-only cardiac coil for highly accelerated cardiac MRI at 3 tesla. Magn Reson Med. 2008;59:1431-1439.
293. Weinmann HJ, Brasch RC, Press WR, et al. Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. AJR Am J Roentgenol. 1984;142:619-624.
294. Brasch RC, Weinmann HJ, Wesbey GE. Contrast-enhanced NMR imaging: animal studies using gadolinium-DTPA complex. AJR Am J Roentgenol. 1984;142:625-630.
295. Carr DH, Brown J, Bydder GM, et al. Intravenous chelated gadolinium as a contrast agent in NMR imaging of cerebral tumours. Lancet. 1984;1:484-486.
296. Magerstadt M, Gansow OA, Brechbiel MW, et al. Gd(DOTA): an alternative to Gd(DTPA) as a T1, 2 relaxation agent for NMR imaging or spectroscopy. Magn Reson Med. 1986;3:808-812.
297. Greco A, McNamara MT, Lanthiez P, et al. Gadodiamide injection: nonionic gadolinium chelate for MR imaging of the brain and spineVphase II-III clinical trial. Radiology. 1990;176:451-456.
298. Pavone P, Patrizio G, Buoni C, et al. Comparison of Gd-BOPTA with Gd-DTPA in MR imaging of rat liver. Radiology. 1990;176:61-64.
299. Runge VM, Gelblum DY, Pacetti ML, et al. Gd-HP-DO3A in clinical MR imaging of the brain. Radiology. 1990;177:393-400.
300. Weinmann HJ, Schuhmann-Giampieri G, Schmitt-Willich H, et al. A new li-pophilic gadolinium chelate as a tissue-specific contrast medium for MRI. Magn Reson Med. 1991;22:233-237; discussion 242.
301. Staks T, Schuhmann-Giampieri G, Frenzel T, et al. Pharmacokinetics, dose proportionality, and tolerability of gadobutrol after single intravenous injection in healthy volunteers. Invest Radiol. 1994;29:709-715.
302. Parmelee DJ, Walovitch RC, Ouellet HS, et al. Preclinical evaluation of the pharmacokinetics, biodistribution, and elimination of MS-325, a blood pool agent for magnetic resonance imaging. Invest Radiol. 1997;32:741-747.
303. Morelli JN, Runge VM, Williams JM, et al. Evaluation of a fibrin-binding gadolinium chelate peptide tetramer in a brain glioma model. Invest Radiol. 2011;46:169-177.
304. Vymazal J, Spuentrup E, Cardenas-Molina G, et al. Thrombus imaging with fibrin-specific gadolinium-based MR contrast agent EP-2104R: results of a phase II clinical study of feasibility. Invest Radiol. 2009;44:697-704.
305. Pattany PM, Phillips JJ, Chiu LC, et al. Motion artifact suppression technique (MAST) for MR imaging. J Comput Assist Tomogr. 1987;11:369-377.
306. Elster AD. Motion artifact suppression technique (MAST) for cranial MR imaging: superiority over cardiac gating for reducing phase-shift artifacts. AJNR Am J Neuroradiol. 1988;9:671-674.
307. Hinks RS, Constable RT. Gradient moment nulling in fast spin echo. Magn Reson Med. 1994;32:698-706.
308. Haacke EM, Patrick JL. Reducing motion artifacts in two-dimensional Fourier transform imaging. Magn Reson Imaging. 1986;4:359-376.
309. Haacke EM, Lenz GW. Improving MR image quality in the presence of motion by using rephasing gradients. AJR Am J Roentgenol. 1987;148:1251-1258.
310. Runge VM, Wood ML. Fast imaging and other motion artifact reduction schemes: a pictorial overview. Magn Reson Imaging. 1988;6:595-607.
311. Atlas SW, Mark AS, Fram EK, et al. Vascular intracranial lesions: applications of gradient-echo MR imaging. Radiology. 1988;169:455-461.
312. Richardson DN, Elster AD, Williams DW 3rd. Gd-DTPA-enhanced MR images: accentuation of vascular pulsation artifacts and correction by using gradient-moment nulling (MAST). AJNR Am J Neuroradiol. 1990;11:209-210.
313. Ehman RL, Felmlee JP. Flowartifact reduction in MRI: a review of the roles of gradient moment nulling and spatial presaturation. Magn Reson Med. 1990;14:293-307.
314. Edelman RR, Atkinson DJ, Silver MS, et al. FRODO pulse sequences: a new means of eliminating motion, flow, and wraparound artifacts. Radiology. 1988;166(1, pt 1):231-236.
315. Felmlee JP, Ehman RL. Spatial presaturation: a method for suppressing flow artifacts and improving depiction of vascular anatomy in MR imaging. Radiology. 1987;164:559-564.
316. Mugler JP 3rd, Brookeman Jr. The design of pulse sequences employing spatial presaturation for the suppression of flow artifacts. Magn Reson Med. 1992;23:201-214.
317. Wikstrom J, Bjornerud A, McGill S, et al. Venous saturation slab causes overestimation of stenosis length in two-dimensional time-of-flight magnetic resonance angiography. Acta Radiol. 2009;50:55-60.
318. Doyle M, Matsuda T, Pohost GM. SLIP, a lipid suppression technique to improve image contrast in inflow angiography. Magn Reson Med. 1991; 21:71-81.
319. Forster J, Schick F, Breuer J, et al. Slice-selective fat saturation in MR angi-ography using spatial-spectral selective prepulses. J Magn Reson Imaging. 1998;8:583-589.
320. Nachabe R, van der Hoorn JW, van de Molengraaf R, et al. Validation of interventional fiber optic spectroscopy with MR spectroscopy, MAS-NMR spectroscopy, high-performance thin-layer chromatography, and histopathol-ogy for accurate hepatic fat quantification. Invest Radiol. 2012;47:209-216.
321. Scheenen TW, Futterer J, Weiland E, et al. Discriminating cancer from non-cancer tissue in the prostate by 3-dimensional proton magnetic resonance spectroscopic imaging: a prospective multicenter validation study. Invest Radiol. 2011;46:25-33.
322. Venugopal N, McCurdy B, Hovdebo J, et al. Automatic conformal prescription of very selective saturation bands for in vivo 1H-MRSI of the prostate. NMR Biomed. 2012;25:643-653.
323. Ozhinsky E, Vigneron DB, Nelson SJ. Improved spatial coverage for brain 3D PRESS MRSI by automatic placement of outer-volume suppression saturation bands. J Magn Reson Imaging. 2011;33:792-802.
324. Johnson KM, Leavitt GD, Kayser HW. Total-body MR imaging in as little as 18 seconds. Radiology. 1997;202:262-267.
325. Eustace S, Tello R, DeCarvalho V, et al. A comparison of whole-body tur-boSTIR MR imaging and planar 99mTc-methylene diphosphonate scintigra-phy in the examination of patients with suspected skeletal metastases. AJR Am J Roentgenol. 1997;169:1655-1661.
326. Kruger DG, Riederer SJ, Grimm RC, et al. Continuously moving table data acquisition method for long FOV contrast-enhanced MRA and whole-body MRI. Magn Reson Med. 2002;47:224-231.
327. Schlemmer HP, Schafer J, Pfannenberg C, et al. Fast whole-body assessment of metastatic disease using a novel magnetic resonance imaging system: initial experiences. Invest Radiol. 2005;40:64-71.
328. Zhang Z, Li J, Wu S, et al. Magnetic resonance imaging/magnetic resonance spectroscopy biomarkers evaluation of stunned myocardium in canine model. Invest Radiol. 2011;46:209-214.
329. Yakar D, Heijmink SW, Hulsbergen-van de Kaa CA, et al. Initial results of 3-dimensional 1H-magnetic resonance spectroscopic imaging in the localization of prostate cancer at 3 tesla: should we use an endorectal coil? Invest Radiol. 2011;46:301-306.
330. Wiesinger B, Kehlbach R, Hemsen J, et al. Effects of magnetic resonance imaging contrast agents on human umbilical vein endothelial cells and evaluation of magnetic resonance imaging contrast media-triggered transforming growth factor-beta induction in dermal fibroblasts (HSF) as a model for nephrogenic systemic fibrosis. Invest Radiol. 2011;46:71-76.
331. Warner L, Yin M, Glaser KJ, et al. Noninvasive in vivo assessment of renal tissue elasticity during graded renal ischemia using MR elastography. Invest Radiol. 2011;46:509-514.
332. Wang H, Miranda Cona M, Chen F, et al. Comparison between nonspecific and necrosis-avid gadolinium contrast agents in vascular disrupting agent-induced necrosis of rodent tumors at 3.0T. Invest Radiol. 2011;46:531-538.
333. Voth M, Rosenberg M, Breuer J. Safety of gadobutrol, a new generation of contrast agents: experience from clinical trials and postmarketing surveillance. Invest Radiol. 2011;46:663-671.
334. Voglein J, Tuttenberg J, Weimer M, et al. Treatment monitoring in gliomas: comparison of dynamic susceptibility-weighted contrast-enhanced and spec-troscopic MRI techniques for identifying treatment failure. Invest Radiol. 2011;46:390-400.
335. Vogel-Claussen J, Shehata ML, Lossnitzer D, et al. Increased right ventricular septomarginal trabeculation mass is a novel marker for pulmonary hypertension: comparison with ventricular mass index and right ventricular mass. Invest Radiol. 2011;46:567-575.
336. Versluis B, Backes WH, van Eupen MG, et al. Magnetic resonance imaging in peripheral arterial disease: reproducibility of the assessment of morphological and functional vascular status. Invest Radiol. 2011;46:11-24.
337. Springer F, Steidle G, Martirosian P, et al. Rapid assessment of longitudinal relaxation time in materials and tissues with extremely fast signal decay using UTE sequences and the variable flip angle method. Invest Radiol. 2011; 46:610-617.
338. Seo HJ, Kim MJ, Lee JD, et al. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colo-rectal liver metastases. Invest Radiol. 2011;46:548-555.
339. Sardanelli F, Podo F, Santoro F, et al. Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the high breast cancer risk Italian 1 study): final results. Invest Radiol. 2011;46:94-105.
340. Runge VM, Ai T, Hao D, et al. The developmental history of the gadolinium chelates as intravenous contrast media for magnetic resonance. Invest Radiol. 2011;46:807-816.
341. Ring J, Persigehl T, Remmele S, et al. Monitoring of bevacizumab-induced antiangiogenic treatment effects by ''steady state'' ultrasmall super-paramagnetic iron oxide particles magnetic resonance imaging using robust multiecho DeltaR2*relaxometry. Invest Radiol. 2011;46:326-330.
342. Raya JG, Melkus G, Adam-Neumair S, et al. Change of diffusion tensor imaging parameters in articular cartilage with progressive proteoglycan extraction. Invest Radiol. 2011;46:401-409.
343. Rapacchi S, Wen H, Viallon M, et al. Low b-value diffusion-weighted cardiac magnetic resonance imaging: initial results in humans using an optimal timewindow imaging approach. Invest Radiol. 2011;46:751-758.
344. Pietsch H, Raschke M, Ellinger-Ziegelbauer H, et al. The role of residual gadolinium in the induction of nephrogenic systemic fibrosis-like skin lesions in rats. Invest Radiol. 2011;46:48-56.
345. Percy DB, Ribot EJ, Chen Y, et al. In vivo characterization of changing blood-tumor barrier permeability in a mouse model of breast cancer metastasis: a complementary magnetic resonance imaging approach. Invest Radiol. 2011; 46:718-725.
346. Nagel AM, Bock M, Hartmann C, et al. The potential of relaxation-weighted sodium magnetic resonance imaging as demonstrated on brain tumors. Invest Radiol. 2011;46:539-547.
347. Nagel AM, Amarteifio E, Lehmann-Horn F, et al. 3 tesla sodium inversion recovery magnetic resonance imaging allows for improved visualization of intracellular sodium content changes in muscular channelopathies. Invest Radiol. 2011;46:759-766.
348. Motosugi U, Ichikawa T, Sano K, et al. Double-dose gadoxetic acid-enhanced magnetic resonance imaging in patients with chronic liver disease. Invest Radiol. 2011;46:141-145.
349. Motosugi U, Ichikawa T, Onohara K, et al. Distinguishing hepatic metastasis from hemangioma using gadoxetic acid-enhanced magnetic resonance imaging. Invest Radiol. 2011;46:359-365.
350. Morana G, Grazioli L, Kirchin MA, et al. Solid hypervascular liver lesions: accurate identification of true benign lesions on enhanced dynamic and hepatobiliary phase magnetic resonance imaging after gadobenate dimeglu-mine administration. Invest Radiol. 2011;46:225-239.
351. Melancon MP, Elliott A, Ji X, et al. Theranostics with multifunctional magnetic gold nanoshells: photothermal therapy and T2*magnetic resonance imaging. Invest Radiol. 2011;46:132-140.
352. MacNeil S, Bains S, Johnson C, et al. Gadolinium contrast agent associated stimulation of human fibroblast collagen production. Invest Radiol. 2011;46:711-717.
353. Lowe A, Breuer J, Palkowitsch P. Evaluation of the effect of two gadolinium-containing contrast-enhancing agents, gadobutrol and gadoxetate disodium, on colorimetric calcium determinations in serum and plasma. Invest Radiol. 2011;46:366-369.
354. Kuhn JP, Evert M, Friedrich N, et al. Noninvasive quantification of hepatic fat content using three-echo dixon magnetic resonance imaging with correction for T2*relaxation effects. Invest Radiol. 2011;46:783-789.
355. Ko SF, Yip HK, Lee CC, et al. Immediate intramyocardial bone marrow-derived mononuclear cells implantation in minipig myocardium after permanent coronary artery ligation: magnetic resonance imaging with histopatho-logic and immunochemical correlation. Invest Radiol. 2011;46:495-503.
356. Klauss M, Lemke A, Grunberg K, et al. Intravoxel incoherent motion MRI for the differentiation between mass forming chronic pancreatitis and pancreatic carcinoma. Invest Radiol. 2011;46:57-63.
357. Kinner S, Maderwald S, Parohl N, et al. Contrast-enhanced magnetic resonance angiography in rabbits: evaluation of the gadolinium-based agent p846 and the iron-based blood pool agent p904 in comparison with gadoterate meglumine. Invest Radiol. 2011;46:524-529.
358. Kim YS, Lim HK, Kim JH, et al. Dynamic contrast-enhanced magnetic resonance imaging predicts immediate therapeutic response of magnetic resonance-guided high-intensity focused ultrasound ablation of symptomatic uterine fibroids. Invest Radiol. 2011;46:639-647.
359. Kim YK, Kim CS, Han YM, et al. Detection of small hepatocellular carcinoma: intraindividual comparison of gadoxetic acid-enhanced MRI at 3.0 and 1.5 T. Invest Radiol. 2011;46:383-389.
360. Katsube T, Okada M, Kumano S, et al. Estimation of liver function using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance imaging. Invest Radiol. 2011;46:277-283.
361. Katakami N, Inaba Y, Sugata S, et al. Magnetic resonance evaluation of brain metastases from systemic malignances with two doses of gadobutrol 1.0 m compared with gadoteridol: a multicenter, phase ii/iii study in patients with known or suspected brain metastases. Invest Radiol. 2011;46:411-418.
362. Jost G, Lenhard DC, Sieber MA, et al. Changes of renal water diffusion coefficient after application of iodinated contrast agents: effect of viscosity. Invest Radiol. 2011;46:796-800.
363. Jacquier A, Prost C, Amabile N, et al. Gadolinium chelate kinetics in cardiac MR imaging of myocarditis: comparison to acute myocardial infarction and impact on late gadolinium enhancement. Invest Radiol. 2011;46:705-710.
364. Haneder S, Attenberger UI, Biffar A, et al. Gadofosveset: parameter optimization for steady-state imaging of the thoracic and abdominal vasculature. Invest Radiol. 2011;46:678-685.
365. Gschwend S, Ebert W, Schultze-Mosgau M, et al. Pharmacokinetics and imaging properties of Gd-EOB-DTPA in patients with hepatic and renal impairment. Invest Radiol. 2011;46:556-566.
366. Fretellier N, Idee JM, Guerret S, et al. Clinical, biological, and skin histo-pathologic effects of ionic macrocyclic and nonionic linear gadolinium chelates in a rat model of nephrogenic systemic fibrosis. Invest Radiol. 2011;46:85-93.
367. Fretellier N, Idee JM, Dencausse A, et al. Comparative in vivo dissociation of gadolinium chelates in renally impaired rats: a relaxometry study. Invest Radiol. 2011;46:292-300.
368. Frericks BB, Kuhl AA, Loddenkemper C, et al. Gadofluorine M-enhanced magnetic resonance imaging of inflammatory bowel disease: quantitative analysis and histologic correlation in a rat model. Invest Radiol. 2011;46:478-485.
369. Esseridou A, Di Leo G, Sconfienza LM, et al. In vivo detection of choline in ovarian tumors using 3D magnetic resonance spectroscopy. Invest Radiol. 2011;46:377-382.
370. Duerschmied D, Meibetaner M, Peter K, et al. Molecular magnetic resonance imaging allows the detection of activated platelets in a new mouse model of coronary artery thrombosis. Invest Radiol. 2011;46:618-623.
371. Donati OF, Alkadhi H, Scheffel H, et al. 3D fusion of functional cardiac magnetic resonance imaging and computed tomography coronary angiogra-phy: accuracy and added clinical value. Invest Radiol. 2011;46:331-340.
372. de Lange C, Brabrand K, Emblem KE, et al. Cerebral perfusion in perinatal hypoxia and resuscitation assessed by transcranial contrast-enhanced ultrasound and 3 T MRI in newborn pigs. Invest Radiol. 2011;46:686-696.
373. Cyran CC, Sourbron S, Bochmann K, et al. Quantification of supra-aortic arterial wall inflammation in patients with arteritis using high resolution dynamic contrast-enhanced magnetic resonance imaging: initial results in correlation to [18F]-FDG PET/CT. Invest Radiol. 2011;46:594-599.
374. Cho EJ, Yang J, Mohamedali KA, et al. Sensitive angiogenesis imaging of orthotopic bladder tumors in mice using a selective magnetic resonance imaging contrast agent containing VEGF121/rGel. Invest Radiol. 2011;46:441-449.
375. Braren R, Curcic J, Remmele S, et al. Free-breathing quantitative dynamic contrast-enhanced magnetic resonance imaging in a rat liver tumor model using dynamic radial T(1) mapping. Invest Radiol. 2011;46:624-631.
376. Biffar A, Baur-Melnyk A, Schmidt GP, et al. Quantitative analysis of the diffusion-weighted steady-state free precession signal in vertebral bone marrow lesions. Invest Radiol. 2011;46:601-609.
377. Bartling SH, Budjan J, Aviv H, et al. First multimodal embolization particles visible on x-ray/computed tomography and magnetic resonance imaging. Invest Radiol. 2011;46:178-186.
378. Artz NS, Wentland AL, Sadowski EA, et al. Comparing kidney perfusion using noncontrast arterial spin labeling MRI and microsphere methods in an interventional swine model. Invest Radiol. 2011;46:124-131.
379. Wibmer A, Aliya Q, Steininger R, et al. Liver transplantation: impaired biliary excretion of gadoxate is associated with an inferior 1-year retransplantation-free survival. Invest Radiol. 2012;47:353-358.
380. Wack C, Steger-Hartmann T, Mylecraine L, et al. Toxicological safety evaluation of gadobutrol. Invest Radiol. 2012;47:611-623.
381. Vignati A, Giannini V, Bert A, et al. A fully automatic multi-scale 3D hessian-based algorithm for vessel detection in breast DCE-MRI. Invest Radiol. 2012. In press.
382. van der Hulst AE, Westenberg JJ, Delgado V, et al. Tissue-velocity magnetic resonance imaging and tissue Doppler imaging to assess regional myocardial diastolic velocities at the right ventricle in corrected pediatric Tetralogy of Fallot patients. Invest Radiol. 2012;47:189-196.
383. Uppal R, Medarova Z, Farrar CT, et al. Molecular imaging of fibrin in a breast cancer xenograft mouse model. Invest Radiol. 2012;47:553-558.
384. Swift AJ, Rajaram S, Condliffe R, et al. Pulmonary artery relative area change detects mild elevations in pulmonary vascular resistance and predicts adverse outcome in pulmonary hypertension. Invest Radiol. 2012;47:571-577.
385. Storey P, Lim RP, Chandarana H, et al. MRI assessment of hepatic iron clearance rates following USPIO administration in healthy adults. Invest Radiol. 2012. In press.
386. Somford DM, Hambrock T, Hulsbergen-van de Kaa CA, et al. Initial experience with identifying high-grade prostate cancer using diffusion-weighted MR imaging (DWI) in patients with a Gleason score e3 + 3 = 6 upon schematic TRUS-guided biopsy: a radical prostatectomy correlated series. Invest Radiol. 2012;47:153-158.
387. Seln&s KM, Heerschap A, Jensen LR, et al. Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 TVunbiased cancer identification by matching to histopathology. Invest Radiol. 2012;47:624-633.
388. Rossi C, Artunc F, Martirosian P, et al. Histogram analysis of renal arterial spin labeling perfusion data reveals differences between volunteers and patients with mild chronic kidney disease. Invest Radiol. 2012;47:490-496.
389. Pediconi F, Miglio E, Telesca M, et al. Effect of preoperative breast magnetic resonance imaging on surgical decision making and cancer recurrence rates. Invest Radiol. 2012;47:128-135.
390. Park J, Kim J, Yoo E, et al. Detection of small metastatic brain tumors: comparison of 3D contrast-enhanced whole-brain black-blood imaging and MP-RAGE imaging. Invest Radiol. 2012;47:136-141.
391. Motosugi U, Ichikawa T, Muhi A, et al. MR elastography as a predictor of insufficient liver enhancement on gadoxetic acid-enhanced hepatocyte-phase MR imaging in patients with type C hepatitis and child-pugh class A disease. Invest Radiol. 2012;47:566-570.
392. Morelli JN, Runge VM, Ai F, et al. Magnetic resonance evaluation of renal artery stenosis in a swine model: performance of low-dose gadobutrol versus gadoterate meglumine in comparison with digital subtraction intra-arterial catheter angiography. Invest Radiol. 2012;47:376-382.
393. Makowski MR, Preissel A, von Bary C, et al. Three-dimensional imaging of the aortic vessel wall using an elastin-specific magnetic resonance contrast agent. Invest Radiol. 2012;47:438-444.
394. Kroner ES, van Schinkel LD, Versluis MJ, et al. Ultra high field 7T MR carotid vessel wall imaging: initial experience in comparison with 3T. Invest Radiol. 2012. [Epub ahead of print].
395. Kinner S, Maderwald S, Albert J, et al. Comparison of two different iron oxide-based contrast agents for discrimination of benign and malignant lymph nodes. Invest Radiol. 2012;47:511-515.
396. Kang BK, Yu ES, Lee SS, et al. Hepatic fat quantification: a prospective comparison of magnetic resonance spectroscopy and analysis methods for chemical-shift gradient echo magnetic resonance imaging with histologic assessment as the reference standard. Invest Radiol. 2012;47:368-375.
397. Johst S, Wrede KH, Ladd ME, et al. Time-of-flight magnetic resonance an-giography at 7 T using venous saturation pulses with reduced flip angles. Invest Radiol. 2012;47:445-450.
398. Husarik DB, Bashir MR, Weber PW, et al. Contrast-enhanced magnetic resonance angiography: first-pass arterial enhancement as a function of gadolinium-chelate concentration, and the saline chaser volume and injection rate. Invest Radiol. 2012;47:121-127.
399. Hueper K, Hartung D, Gutberlet M, et al. Magnetic resonance diffusion tensor imaging for evaluation of histopathological changes in a rat model of diabetic nephropathy. Invest Radiol. 2012;47:430-437.
400. Huber A, Sourbron S, Klauss V, et al. Magnetic resonance perfusion of the myocardium: semiquantitative and quantitative evaluation in comparison with coronary angiography and fractional flow reserve. Invest Radiol. 2012;47:332-338.
401. Hausmann D, Konstandin S, Wetterling F, et al. Apparent diffusion coefficient and sodium concentration measurements in human prostate tissue via hydro-gen-1 and sodium-23 magnetic resonance imaging in a clinical setting at 3T. Invest Radiol. 2012. [Epub ahead of print].
402. Haneder S, Augustin J, Jost G, et al. Impact of iso-and low-osmolar iodinated contrast agents on BOLD and diffusion MRI in swine kidneys. Invest Radiol. 2012;47:299-305.
403. Gharib AM, Abd-Elmoniem KZ, Ho VB, et al. The feasibility of 350 Km spatial resolution coronary magnetic resonance angiography at 3 T in humans. Invest Radiol. 2012;47:339-345.
404. Durmus T, Schilling R, Doeblin P, et al. Gadobutrol for magnetic resonance imaging of chronic myocardial infarction: intraindividual comparison with gadopentetate dimeglumine. Invest Radiol. 2012;47:183-188.
405. Donker HC, Kramer NA, Otto J, et al. Mapping of proton relaxation near superparamagnetic iron oxide particle-loaded polymer threads for magnetic susceptibility difference quantification. Invest Radiol. 2012;47:359-367.
406. Delattre B, Viallon M, Wei H, et al. In vivo cardiac diffusion-weighted MRI: quantification of normal perfusion and diffusion coefficients with intravoxel incoherent motion imaging. Invest Radiol. 2012;47:662-670.
407. Dassler K, Roohi F, Lohrke J, et al. Current limitations of molecular magnetic resonance imaging for tumors as evaluated with high-relaxivity CD105-specific iron oxide nanoparticles. Invest Radiol. 2012;47:383-391.
408. Chen BB, Hsu CY, Yu CW, et al. Clinical and histologic implications of delayed hepatobiliary enhancement on magnetic resonance imaging with gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid. Invest Radiol. 2012;47:649-655.
409. Chandarana H, Kang SK, Wong S, et al. Diffusion-weighted intravoxel incoherent motion imaging of renal tumors with histopathologic correlation. Invest Radiol. 2012. [Epub ahead of print].
410. Bun SS, Kober F, Jacquier A, et al. Value of in vivo T2 measurement for myocardial fibrosis assessment in diabetic mice at 11.75 T. Invest Radiol. 2012;47:319-323.
411. Bittersohl B, Miese FR, Hosalkar HS, et al. T2*mapping of acetabular and femoral hip joint cartilage at 3 T: a prospective controlled study. Invest Radiol. 2012;47:392-397.
412. Bashir MR, Dale BM, Gupta RT, et al. Gradient shimming during magnetic resonance imaging of the liver: comparison of a standard protocol versus a novel reduced protocol. Invest Radiol. 2012;47:524-529.
413. An C, Choi GH, Lee HS, et al. Assessment of preoperative magnetic resonance imaging staging in patients with hepatocellular carcinoma undergoing resection compared with the Seventh American Joint Committee on Cancer System. Invest Radiol. 2012;47:634-641.
414. Wu B, Millane RP, Watts R, et al. Prior estimate-based compressed sensing in parallel MRI. Magn Reson Med. 2011;65:83-95.
415. Sharp JC, King SB. MRI using radiofrequency magnetic field phase gradients. Magn Reson Med. 2010;63:151-161.